Odyssey Health Swings to Q3 Net Income of $766K, Reports $0.01 EPS
ODYY sits 48% above its 52-week low of $0.005.
Summary
Odyssey Health reported a net income of $766K and $0.01 EPS for Q3 2026, a notable swing from a $252K net loss in the year-ago quarter. This quarterly profit provides a positive data point for the micro-cap company, which previously reported a 'going concern' warning in its last 10-Q. However, the year-to-date net loss widened to $3.32M, and the company's core medical device products remain in R&D with no commercial sales. R&D spending has been temporarily paused due to funding constraints, highlighting ongoing financial challenges despite the quarterly profit. The company has started generating a small new revenue stream from facility maintenance services, expected to bring in $252K annually.
At the time of this announcement, ODYY was trading at $0.01 on OTC in the Life Sciences sector, with a market capitalization of approximately $679K. The 52-week trading range was $0.00 to $0.13. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.